Enliven Therapeutics Bolsters Board to Prepare for Next Phase of Development
Go back to Enliven Therapeutics Bolsters Board to Prepare for Next Phase of Development| (NASDAQ: ELVN) | Delayed: 40.98 +0.35 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.63 | 52 Week High | $ | |||
| Open | $41.00 | 52 Week Low | $ | |||
| Day High | $42.06 | P/E | N/A | |||
| Day Low | $40.29 | EPS | $ | |||
| Volume | 1,002,683 | |||||



